Olezarsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)
Clinical trial NCT06360237 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT06360237
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.